Nebulised Dornase Alfa for Treatment of COVID-19

Conditions:   COVID19;   Hypoxia Intervention:   Drug: Dornase Alfa Inhalation Solution [Pulmozyme] Sponsor:   University College, London Not yet recruiting

Source: ClinicalTrials.gov - April 24, 2020 Category: Research Source Type: clinical trials